CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean C. Tien, Arul M. Chinnaiyan, Yunhui Cheng et al.|Cell Reports Medicine|2024Cited by 28
The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint BlockadeYi Bao, Arul M. Chinnaiyan|Cancer Discovery|2024Cited by 9